Studies how well abiraterone acetate and antiandrogen therapy, with or without cabazitaxel and prednisone, work in treating patients with castration-resistant prostate cancer previously treated with docetaxel that has spread to other parts of the body.

Clinical Program: Urological Oncology Program
Cancer Type & Condition: Prostate Cancer
Principal Investigator: Jianqing Lin
Contact Info: (202) 994-0450